---
figid: PMC3630242__nihms437502f1
figlink: /pmc/articles/PMC3630242/figure/F1/
number: F1
caption: Leptin and adiponectin activate signaling components that integrate PI3K/Akt,
  RAS/MAPK, and pAMPK/mTor pathways. Green arrows indicate activation of target protein,
  while red lines indicate inhibitory effects. Leptin stimulation of the long receptor
  isoform leads to JAK2 phosphorylation and subsequent phosphorylation of tyrosine
  residues 985 and 1138, which confer PI3K/Akt and STAT3 pathway activation. Leptin
  stimulation can be prevented with c-reactive peptide, soluble leptin receptor (Ob-Re)
  or leptin antagonists. Chronic stimulation leads to an increase in SOCS3 which negatively
  regulates leptin signaling by inhibiting JAK2 activities. Additionally, leptin receptor
  stimulation activates SHP2 leading to increased Ras/RAF/ERK signaling. Adiponectin
  receptor 1 (AdipoR1) and receptor 2 (AdipoR2) are preferentially stimulated by the
  globular (gAdn) and high molecular weight (HMW Adn) oligomers of adiponectin respectively,
  although both receptors respond with lower affinity to other adiponectin oligomers.
  Serum levels of adiponectin can be increased through thiazolidinediones or fenofibrates,
  while the receptor levels can be increased with rosiglitazone or exercise. Adiponectin
  receptors associate with adaptor protein APPL1 to activate AMPK and PPAR alpha.
  Adiponectin can antagonize leptin mediated proliferation through activation of phosphatase
  PTP1B, leading to inhibition of JAK2, dephosphorylation of STAT3, and dephosphorylation
  of ERK1/2; as well as phosphatase PP2A to decrease phosphor-Akt. Adiponectin also
  inhibits leptin action through increased AMPK inhibition on mTORC1 directly as well
  as indirectly through TSC2. Metformin additionally antagonizes leptin action through
  activation of AMPK. Adiponectin activation also leads to modulation of NFkB, TP53,
  eNOS, ACC, and ceramidase activity; yet direct antagonism of leptin through these
  mediators is unclear. Ultimate outcome for a particular pathway in cancer is highly
  dependent upon genetic integrity and deficiencies in key regulatory mediators will
  dictate which pathway will dominate.
pmcid: PMC3630242
papertitle: 'Molecular Pathways: Adiponectin and Leptin Signaling in Cancer.'
reftext: Michael N. VanSaun. Clin Cancer Res. ;19(8):1926-1932.
pmc_ranked_result_index: '27725'
pathway_score: 0.9488663
filename: nihms437502f1.jpg
figtitle: Leptin and adiponectin activate signaling components that integrate PI3K/Akt,
  RAS/MAPK, and pAMPK/mTor pathways
year: ''
organisms: Homo sapiens
ndex: 74f45898-deec-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3630242__nihms437502f1.html
  '@type': Dataset
  description: Leptin and adiponectin activate signaling components that integrate
    PI3K/Akt, RAS/MAPK, and pAMPK/mTor pathways. Green arrows indicate activation
    of target protein, while red lines indicate inhibitory effects. Leptin stimulation
    of the long receptor isoform leads to JAK2 phosphorylation and subsequent phosphorylation
    of tyrosine residues 985 and 1138, which confer PI3K/Akt and STAT3 pathway activation.
    Leptin stimulation can be prevented with c-reactive peptide, soluble leptin receptor
    (Ob-Re) or leptin antagonists. Chronic stimulation leads to an increase in SOCS3
    which negatively regulates leptin signaling by inhibiting JAK2 activities. Additionally,
    leptin receptor stimulation activates SHP2 leading to increased Ras/RAF/ERK signaling.
    Adiponectin receptor 1 (AdipoR1) and receptor 2 (AdipoR2) are preferentially stimulated
    by the globular (gAdn) and high molecular weight (HMW Adn) oligomers of adiponectin
    respectively, although both receptors respond with lower affinity to other adiponectin
    oligomers. Serum levels of adiponectin can be increased through thiazolidinediones
    or fenofibrates, while the receptor levels can be increased with rosiglitazone
    or exercise. Adiponectin receptors associate with adaptor protein APPL1 to activate
    AMPK and PPAR alpha. Adiponectin can antagonize leptin mediated proliferation
    through activation of phosphatase PTP1B, leading to inhibition of JAK2, dephosphorylation
    of STAT3, and dephosphorylation of ERK1/2; as well as phosphatase PP2A to decrease
    phosphor-Akt. Adiponectin also inhibits leptin action through increased AMPK inhibition
    on mTORC1 directly as well as indirectly through TSC2. Metformin additionally
    antagonizes leptin action through activation of AMPK. Adiponectin activation also
    leads to modulation of NFkB, TP53, eNOS, ACC, and ceramidase activity; yet direct
    antagonism of leptin through these mediators is unclear. Ultimate outcome for
    a particular pathway in cancer is highly dependent upon genetic integrity and
    deficiencies in key regulatory mediators will dictate which pathway will dominate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFC
  - RAC3
  - TSC2
  - HRAS
  - MAPK3
  - NRAS
  - RAF1
  - PTPN1
  - ACACB
  - MAPK1
  - KRAS
  - RAC2
  - NOS3
  - AKT2
  - APPL1
  - CFD
  - RAC1
  - ACACA
  - ADIPOR1
  - RHOG
  - PIK3R4
  - ADIPOR2
  - MBTPS1
  - PIK3R5
  - TP53
  - PTEN
  - NFKB1
  - NFKB2
  - CRP
  - VEGFD
  - PGF
  - RELB
  - DOK1
  - VEGFA
  - PIK3CA
  - PIK3CB
  - PTPN11
  - SOCS3
  - AKT1
  - CFAP97
  - IRS1
  - REL
  - RELA
  - CCND1
  - FOS
  - PIK3R3
  - PIK3R6
  - VEGFB
  - SLC2A4RG
  - SLC2A4
  - AKT3
  - RPTOR
  - MTOR
  - PIK3CG
  - IRS2
  - JAK2
  - PPARA
  - JUN
  - PPA2
  - PIK3CD
  - Fatty Acid
  - Metformin
  - Fenofibrate
  - Thiazolidinediones
  - Cancer
  - Lung cancer
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PTP1B
  symbol: PTP1B
  source: hgnc_prev_symbol
  hgnc_symbol: PTPN1
  entrez: '5770'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras-GDP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: APPL1
  symbol: APPL1
  source: hgnc_symbol
  hgnc_symbol: APPL1
  entrez: '26060'
- word: Adn
  symbol: ADN
  source: hgnc_alias_symbol
  hgnc_symbol: CFD
  entrez: '1675'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: AdipoR1
  symbol: ADIPOR1
  source: hgnc_symbol
  hgnc_symbol: ADIPOR1
  entrez: '51094'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AdipoR2
  symbol: ADIPOR2
  source: hgnc_symbol
  hgnc_symbol: ADIPOR2
  entrez: '79602'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: CRP,
  symbol: CRP
  source: hgnc_symbol
  hgnc_symbol: CRP
  entrez: '1401'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: p62Dok
  symbol: p62dok
  source: hgnc_alias_symbol
  hgnc_symbol: DOK1
  entrez: '1796'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HMW
  symbol: hmw
  source: hgnc_alias_symbol
  hgnc_symbol: CFAP97
  entrez: '57587'
- word: IRS1/2
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: FOS,JUN
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IRS1/2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PPARA
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: FOS,JUN
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: PPA2
  symbol: PPA2
  source: hgnc_symbol
  hgnc_symbol: PPA2
  entrez: '27068'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals:
- word: Fatty Acid
  source: MESH
  identifier: D005227
- word: Metformin
  source: MESH
  identifier: D008687
- word: Fenofibrate
  source: MESH
  identifier: D011345
- word: Thiazolidinediones
  source: MESH
  identifier: D045162
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3630242__F1
redirect_from: /figures/PMC3630242__F1
figtype: Figure
---
